Abstract
Low-dose treatment with acetylsalicylic acid (ASA) is widely recommended to type 2 diabetic patients as primary prevention against cardiovascular disease. High-dose treatment with cyclooxygenase inhibitors reduces urinary albumin excretion rate (AER) in type 1 diabetic patients with micro- or macroalbuminuria. Whether a similar effect on AER exists during low-dose ASA treatment, which may confound the diagnosis and monitoring of micro- and macroalbuminuria in type 2 diabetic patients, remains to be elucidated.
| Original language | English |
|---|---|
| Journal | Nephrology, Dialysis, Transplantation |
| Volume | 18 |
| Issue number | 3 |
| Pages (from-to) | 539-42 |
| Number of pages | 4 |
| ISSN | 0931-0509 |
| Publication status | Published - 2003 |
Keywords
- Adult
- Aged
- Albuminuria
- Aspirin
- Cardiovascular Diseases
- Cross-Over Studies
- Diabetes Mellitus, Type 2
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Fibrinolytic Agents
- Glomerular Filtration Rate
- Hemodynamics
- Humans
- Kidney
- Male
- Middle Aged
- Time Factors
